The future of API toxicology is moving towards more predictive and personalized approaches. Advances in in silico modeling, such as computer simulations, are being developed to predict toxicological outcomes more accurately. Additionally, personalized medicine approaches consider individual genetic makeup to tailor drug therapies, potentially reducing the risk of adverse reactions. These advancements aim to enhance the safety and efficacy of APIs, ultimately improving patient outcomes.
